Brief: Lobe Sciences Announces Data On Combination Therapeutic Candidates In mTBI And PTSD
28/09/2021 13:14
Sept 28 (Reuters) - Lobe Sciences Ltd LOBE.CD :
* LOBE SCIENCES ANNOUNCES DATA DEMONSTRATING THAT ITS
COMBINATION
THERAPEUTIC CANDIDATES ARE SIGNIFICANTLY MORE EFFECTIVE THAN
MONOTHERAPY IN MTBI AND PTSD
Source text for Eikon: ID:nCNWTmlN8a
Further company coverage: LOBE.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lobe Sciences
See all newsBrief: Lobe Sciences Announces Creation Of Wholly Owned Subsidiary, Alera Pharma
Brief: Lobe Sciences Announces Update
Brief: Lobe Sciences Announces Frederick D. Sancilio Ph.D. To Join Board Of Directors
Brief: Former Merck Director And Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, To Join Lobe Sciences Board Of Directors
Brief: Lobe Sciences Initiates Phase 1 Clinical Trial Of L-130